Skip to main content
Steven Bair, MD, Hematology, Aurora, CO

Steven M Bair MD


Clinical Fellow in Hematology/Oncology at the Hospital of the University of Pennsylvania

Request appointment
  • 1665 Aurora CtAurora, CO 80045

  • Book by Phone+1(754) 266-3043

  • Fax+1 720-848-1786

Overview of  Dr. Bair

Dr. Steven Bair is a hematologist in Aurora, CO and is affiliated with UCHealth University of Colorado Hospital. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 12 years. He is one of 24 doctors at UCHealth University of Colorado Hospital who specialize in Hematology. He has more than 20 publications and over 500 citings.

Education & Training

  • University of Pennsylvania
    University of PennsylvaniaMSCE, Clinical Epidemiology, 2018 - 2020
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2017 - 2020
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2014

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2020 - 2027
  • WY State Medical License
    WY State Medical License 2021 - 2027
  • PA State Medical License
    PA State Medical License 2014 - 2021
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • The Myron F. Kanter and Lawrence J. Kanter Endowment Award (Cardiology) Case Western Reserve University School of Medicine, 2014
  • Alpha Omega Alpha Inductee Alpha Omega Alpha, 2014

Publications & Presentations

PubMed

Abstracts/Posters

  • Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
    Steven M. Bair, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
    Steven M. Bair, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • The Utility of FDG-PET in the Treatment of Hodgkin Lymphoma
    The Utility of FDG-PET in the Treatment of Hodgkin LymphomaNovember 6th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: